These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10471407)

  • 1. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
    Ménoret A; Peng P; Srivastava PK
    Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
    Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
    Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD91: a receptor for heat shock protein gp96.
    Binder RJ; Han DK; Srivastava PK
    Nat Immunol; 2000 Aug; 1(2):151-5. PubMed ID: 11248808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the immunomodulatory role of the heat shock protein gp96.
    Robert J; Cohen N; Maniero GD; Goyos A; Morales H; Gantress J
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):263-75. PubMed ID: 12887107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation?
    Srivastava PK; Heike M
    Semin Immunol; 1991 Jan; 3(1):57-64. PubMed ID: 1893123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins.
    Binder RJ; Kelly JB; Vatner RE; Srivastava PK
    J Immunol; 2007 Dec; 179(11):7254-61. PubMed ID: 18025167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
    Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
    Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
    Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
    J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.
    Suriano R; Ghosh SK; Ashok BT; Mittelman A; Chen Y; Banerjee A; Tiwari RK
    Cancer Res; 2005 Jul; 65(14):6466-75. PubMed ID: 16024652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
    Udono H; Srivastava PK
    J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
    Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
    J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection.
    Yamazaki K; Nguyen T; Podack ER
    J Immunol; 1999 Nov; 163(10):5178-82. PubMed ID: 10553037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved.
    Robert J; Ménoret A; Cohen N
    J Immunol; 1999 Oct; 163(8):4133-9. PubMed ID: 10510348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96.
    Goyos A; Cohen N; Gantress J; Robert J
    Eur J Immunol; 2004 Sep; 34(9):2449-58. PubMed ID: 15307177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.